Clinical Development Vice President - Neurodegeneration

• Early-stage clinical trials in USA for neurodegeneration disease
• High visibility to shape the promising therapeutic area.

About Our Client

This position in the discovery and development of transformational therapies that address the root cause of age-related degenerative disease.

Job Description

• Provide strategic and scientific oversight for the planning and execution of early-stage clinical trials in neurodegeneration.
• Design and implement clinical development plans, including study protocols, timelines, and endpoints aligned with regulatory and commercial goals.
• Serve as the clinical initiator for interactions with regulatory authorities (FDA, IRBs) for early development programs.
• Oversee clinical trial site selection, investigator engagement, and vendor management (e.g., CROs, biometrics, medical monitoring).
• Interpret clinical trial data and ensure timely, high-quality reporting.
• Work with preclinical, translational, regulatory, and CMC teams to do IND filings and study readiness.
• Represent the company in key scientific, clinical, and regulatory discussions.
• Build and mentor a high-performing clinical development team as the organization scales.

The Successful Applicant

Qualifications

• MD or MD/PhD with board certification in neurology, psychiatry, or related discipline strongly preferred.
• 10+ years of industry experience in clinical development, with a strong focus on neurodegenerative diseases.
• Proven track record in early-stage drug development (Phase I-II), including IND submissions and clinical trial in the U.S.
• Deep of neurodegeneration pathophysiology, clinical endpoints, biomarkers, and patient populations.
• Strong problem solving, and cross-functional communication skill.
• Passion for innovation in aging and neurobiology, with a science and patient-centric mindset.
• Experience in a fast-paced biotech or small company environment is highly desirable.

What's on Offer

Why join us:

Be at the forefront of transforming the way we treat age-related neurodegenerative diseases.

Work with a mission-orientate, science-first team to bold innovation and real-world impact.